4 stocks to watch on Tuesday: META, LLY, BA, TAK

56.68BUSD
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8740602052
CUSIP
874060106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
0.46
Book Value
14.36
Dividend Share
200
Dividend Yield
3.47%
Earnings Share
-0.29
Wall Street Target Price
21.34
EPS Estimate Current Year
49.21
EPS Estimate Next Year
94.98
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
4,505,720,061,952
Gross Profit TTM
2,886,506,119,168
EBITDA
1,236,273,987,584
Profit Margin
-3.38%
Return On Assets TTM
2.55%
Return On Equity TTM
-2.12%
Revenue Per Share TTM
1430.331
Qtly Revenue Growth YOY
3.90%
Diluted Eps TTM
-0.29
Qtly Earnings Growth YOY
330.20%
Trailing PE
0.00
Forward PE
11
Price Sales TTM
0.0122
Price Book MRQ
1.2496
Enterprise Value Revenue
3
Enterprise Value EBITDA
18
45.10
4.37%84.07
2.29%169.12
1.73%77.35
1.72%225.00
0.65%32.96
0.15%28.40
0.00%32.53
-6.90%9.87
-2.37%34.59
-2.27%